AU3692895A - Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring - Google Patents
Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ringInfo
- Publication number
- AU3692895A AU3692895A AU36928/95A AU3692895A AU3692895A AU 3692895 A AU3692895 A AU 3692895A AU 36928/95 A AU36928/95 A AU 36928/95A AU 3692895 A AU3692895 A AU 3692895A AU 3692895 A AU3692895 A AU 3692895A
- Authority
- AU
- Australia
- Prior art keywords
- carbocyclic ring
- base attached
- nucleoside analogues
- substituted benzimidazole
- antiviral nucleoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 125000002837 carbocyclic group Chemical group 0.000 title 1
- 229940127073 nucleoside analogue Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US304006 | 1994-09-09 | ||
| US08/304,006 US5534535A (en) | 1992-03-09 | 1994-09-09 | Therapeutic nucleosides |
| PCT/US1995/011366 WO1996007646A1 (en) | 1994-09-09 | 1995-09-11 | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3692895A true AU3692895A (en) | 1996-03-27 |
Family
ID=23174626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU36928/95A Abandoned AU3692895A (en) | 1994-09-09 | 1995-09-11 | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0779885A1 (en) |
| JP (1) | JPH10505092A (en) |
| CN (1) | CN1164855A (en) |
| AP (1) | AP741A (en) |
| AU (1) | AU3692895A (en) |
| BR (1) | BR9508826A (en) |
| CA (1) | CA2199502A1 (en) |
| CZ (1) | CZ71297A3 (en) |
| FI (1) | FI970959A (en) |
| HU (1) | HUT77440A (en) |
| IS (1) | IS4436A (en) |
| NO (1) | NO971070L (en) |
| NZ (1) | NZ294095A (en) |
| OA (1) | OA10601A (en) |
| PL (1) | PL319440A1 (en) |
| SK (1) | SK29197A3 (en) |
| WO (1) | WO1996007646A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5912356A (en) * | 1995-09-11 | 1999-06-15 | Glaxo Wellcome Inc. | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
| GB9600142D0 (en) * | 1996-01-05 | 1996-03-06 | Wellcome Found | Chemical compounds |
| WO1998035977A1 (en) | 1997-02-13 | 1998-08-20 | Glaxo Group Limited | Benzimidazole derivatives |
| PL338454A1 (en) | 1997-07-30 | 2000-11-06 | Univ Michigan | Lixofuranosilbenzimidazoles as antiviral agents |
| ID30204A (en) | 1999-12-27 | 2001-11-15 | Japan Tobacco Inc | COMPOUNDS OF DIFFUSED RING AND ITS USE AS A MEDICINE |
| US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
| GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
| AR035543A1 (en) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | THERAPEUTIC AGENT FOR HEPATITIS C THAT INCLUDES A CONDENSED RING COMPOUND, CONDENSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS, BENZIMIDAZOL, THIAZOL AND BIFENYL COMPOUNDS USED AS INTERMEDIARY COMPARTMENTS OF COMPARTMENTS |
| CN1834090B (en) * | 2005-03-18 | 2011-06-29 | 中国科学院上海药物研究所 | Benzimidazole compounds, its preparation and uses |
| ES2655028T3 (en) | 2007-08-02 | 2018-02-16 | Millennium Pharmaceuticals, Inc. | Process for the synthesis of E1 activation enzyme inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
-
1995
- 1995-09-11 HU HU9702310A patent/HUT77440A/en unknown
- 1995-09-11 SK SK291-97A patent/SK29197A3/en unknown
- 1995-09-11 NZ NZ294095A patent/NZ294095A/en unknown
- 1995-09-11 CN CN95196148A patent/CN1164855A/en active Pending
- 1995-09-11 AU AU36928/95A patent/AU3692895A/en not_active Abandoned
- 1995-09-11 WO PCT/US1995/011366 patent/WO1996007646A1/en not_active Application Discontinuation
- 1995-09-11 EP EP95934402A patent/EP0779885A1/en not_active Withdrawn
- 1995-09-11 JP JP8509679A patent/JPH10505092A/en not_active Ceased
- 1995-09-11 BR BR9508826A patent/BR9508826A/en not_active Application Discontinuation
- 1995-09-11 CA CA002199502A patent/CA2199502A1/en not_active Abandoned
- 1995-09-11 CZ CZ97712A patent/CZ71297A3/en unknown
- 1995-09-11 PL PL95319440A patent/PL319440A1/en unknown
- 1995-09-11 AP APAP/P/1997/000940A patent/AP741A/en active
-
1997
- 1997-03-06 FI FI970959A patent/FI970959A/en unknown
- 1997-03-07 OA OA60973A patent/OA10601A/en unknown
- 1997-03-07 NO NO971070A patent/NO971070L/en unknown
- 1997-03-07 IS IS4436A patent/IS4436A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1164855A (en) | 1997-11-12 |
| PL319440A1 (en) | 1997-08-04 |
| FI970959A0 (en) | 1997-03-06 |
| AP9700940A0 (en) | 1997-04-30 |
| SK29197A3 (en) | 1997-10-08 |
| NO971070L (en) | 1997-05-07 |
| AP741A (en) | 1999-04-26 |
| MX9701789A (en) | 1997-10-31 |
| CZ71297A3 (en) | 1997-08-13 |
| FI970959A (en) | 1997-05-06 |
| NZ294095A (en) | 1998-08-26 |
| WO1996007646A1 (en) | 1996-03-14 |
| CA2199502A1 (en) | 1996-03-14 |
| JPH10505092A (en) | 1998-05-19 |
| OA10601A (en) | 2002-09-03 |
| HUT77440A (en) | 1998-04-28 |
| BR9508826A (en) | 1997-09-30 |
| EP0779885A1 (en) | 1997-06-25 |
| NO971070D0 (en) | 1997-03-07 |
| IS4436A (en) | 1997-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL113432A0 (en) | Diastereoselective synthesis of nucleoside analogues | |
| AU6597898A (en) | Creatine analogs having antiviral activity | |
| IL98918A0 (en) | Carbocyclic analogs of certain nucleosides | |
| AU8372991A (en) | Novel carbocyclic adenosine analogs useful as immunosuppressants | |
| AU4479189A (en) | Antiviral agents | |
| AU3692895A (en) | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring | |
| EP1019404A4 (en) | Purine acyclonucleosides as antiviral agents | |
| ZA876673B (en) | Nucleoside analogues | |
| AU4654289A (en) | Nucleoside analogues | |
| AU4378589A (en) | Carbocyclic nucleoside analogs | |
| AU4504589A (en) | New antiviral agents | |
| ZA95437B (en) | Production of nucleoside analogues | |
| IE893412L (en) | Carbocyclic nucleoside analogues | |
| ZA917151B (en) | Carbocyclic nucleoside analogs useful as immunosuppressants | |
| GB9222203D0 (en) | Nucleoside analogues | |
| AU630953B2 (en) | Nucleoside analogs | |
| AU2822089A (en) | Antiviral agent | |
| GB9122431D0 (en) | Nucleoside analogues | |
| GB9110081D0 (en) | Nucleoside analogues | |
| ZA917152B (en) | Novel carbocyclic adenosine analogs useful as immunosuppressants | |
| GB8816117D0 (en) | Antiviral nucleosides | |
| GB8813680D0 (en) | Antiviral compounds | |
| GB8810319D0 (en) | Antiviral compounds | |
| GB8813679D0 (en) | Antiviral compounds | |
| GB8921457D0 (en) | Nucleoside analogues |